Companion Spine has raised US$55 million in a Series A financing round, with the money going towards the development and commercialisation of its range of minimally invasive diagnostic and therapeutic solutions in the United States and internationally for the treatment of degenerative disc dis
Fighters appeal for evacuation of wounded from Mariupol mill
Fighters of the Azov Regiment, the Ukrainian unit holed up in the besieged Azovstal steel mill in the devastated port city of Mariupol, have released photos of their wounded comrades in arms who they say are in the plant, along
Theradaptive's OsteoAdapt SP implant received its third FDA breakthrough designation.
The new indication is for anterior lumbar interbody spinal fusion, according to a June 22 news release. It has two other breakthrough designations for transforaminal interbody and posterolateral fusion,
Theradaptive's OsteoAdapt SP implant received its third FDA breakthrough designation.
The new indication is for anterior lumbar interbody spinal fusion, according to a June 22 news release. It has two other breakthrough designations for transforaminal interbody and posterolateral fusion,
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
June 10, 2022 11:04 ET | Source: ReportLinker ReportLinker
ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance t
CARLSBAD, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) ( ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States
There were 743 press releases posted in the last 24 hours and 196,792 in the last 365 days.
The rising occurrence of spinal disorders is one of the significant factors influencing the market growth
VANCOUVER, BRITISH COLUMBIA, CANADA, June 21, 2022 /EINPresswire.com
NEW YORK, June 1, 2022 /PRNewswire/ — A multicenter, prospective, randomized controlled trial is designed to assess the effectiveness of three different disc replacement devices used for two-level symptomatic cervical disc disease. The study is sponsored by Centinel S